Clinical Trial Update: Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin, everolimus, and prednisone in metastatic prostate cancer post-docetaxel; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Everolimus (everolimus)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-25